Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunities
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunities ; volume:37 ; number:1 ; day:13 ; month:3 ; year:2018 ; pages:1-10 ; date:12.2018
Journal of experimental & clinical cancer research ; 37, Heft 1 (13.3.2018), 1-10, 12.2018
- Creator
-
Porru, Manuela
- Contributor
-
Pompili, Luca
Caruso, Carla
Biroccio, Annamaria
Leonetti, Carlo
SpringerLink (Online service)
- DOI
-
10.1186/s13046-018-0719-1
- URN
-
urn:nbn:de:1111-201805172262
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Porru, Manuela
- Pompili, Luca
- Caruso, Carla
- Biroccio, Annamaria
- Leonetti, Carlo
- SpringerLink (Online service)
Other Objects (12)
Advances in KRAS mutation inhibition in metastatic colorectal cancer
Targeting Myc-driven stress vulnerability in mutant KRAS colorectal cancer
Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer
Reliability of KRAS mutation testing in metastatic colorectal cancer patients across five laboratories
Colorectal cancer with KRAS mutation
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer
KRAS mutation analysis of single circulating tumor cells from patients with metastatic colorectal cancer
Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer
KRAS mutations: variable incidences in a Brazilian cohort of 8,234 metastatic colorectal cancer patients
The pattern of KRAS mutations in metastatic colorectal cancer: a retrospective audit from Sri Lanka
KRAS Status is Associated with Metabolic Parameters in Metastatic Colorectal Cancer According to Primary Tumour Location
Concordance of KRAS/BRAF Mutation Status in Metastatic Colorectal Cancer before and after Anti-EGFR Therapy
Advances in KRAS mutation inhibition in metastatic colorectal cancer
Targeting Myc-driven stress vulnerability in mutant KRAS colorectal cancer
Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer
Reliability of KRAS mutation testing in metastatic colorectal cancer patients across five laboratories
Colorectal cancer with KRAS mutation
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer
KRAS mutation analysis of single circulating tumor cells from patients with metastatic colorectal cancer
Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer
KRAS mutations: variable incidences in a Brazilian cohort of 8,234 metastatic colorectal cancer patients
The pattern of KRAS mutations in metastatic colorectal cancer: a retrospective audit from Sri Lanka
KRAS Status is Associated with Metabolic Parameters in Metastatic Colorectal Cancer According to Primary Tumour Location
Concordance of KRAS/BRAF Mutation Status in Metastatic Colorectal Cancer before and after Anti-EGFR Therapy
Advances in KRAS mutation inhibition in metastatic colorectal cancer
Targeting Myc-driven stress vulnerability in mutant KRAS colorectal cancer
Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer
Reliability of KRAS mutation testing in metastatic colorectal cancer patients across five laboratories
Colorectal cancer with KRAS mutation
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer
KRAS mutation analysis of single circulating tumor cells from patients with metastatic colorectal cancer
Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer
KRAS mutations: variable incidences in a Brazilian cohort of 8,234 metastatic colorectal cancer patients
The pattern of KRAS mutations in metastatic colorectal cancer: a retrospective audit from Sri Lanka
KRAS Status is Associated with Metabolic Parameters in Metastatic Colorectal Cancer According to Primary Tumour Location